Svelte Medical Systems, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://svelte.dev/
Clinical Trials
8
Active:1
Completed:6
Trial Phases
3 Phases
Phase 1:1
Phase 4:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (60.0%)Phase 1
1 (20.0%)Phase 4
1 (20.0%)OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
Not Applicable
Active, not recruiting
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- Svelte Medical Systems, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03716102
- Locations
- 🇺🇸
Scottsdale Healthcare, Scottsdale, Arizona, United States
🇺🇸Northern Michigan Hospital d.b.a McLaren Northern Michigan, Petoskey, Michigan, United States
OPTIMIZE IDE for the Treatment of ACS
Not Applicable
Terminated
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Svelte Medical Systems, Inc.
- Target Recruit Count
- 1630
- Registration Number
- NCT03190473
- Locations
- 🇺🇸
Thomas Hospital, Fairhope, Alabama, United States
🇺🇸Scottsdale Healthcare, Scottsdale, Arizona, United States
🇺🇸Arkansas Heart Hospital, Little Rock, Arkansas, United States
The Direct III Post Market Study
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- Svelte Medical Systems, Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT02693158
- Locations
- 🇳🇱
Meander Medical Center, Amersfoort, Netherlands
🇳🇱OLVG, Amsterdam, Netherlands
🇳🇱Tergooi Hospital, Blaricum, Netherlands
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- Svelte Medical Systems, Inc.
- Target Recruit Count
- 159
- Registration Number
- NCT01788150
- Locations
- 🇧🇪
OLV Ziekenhuis Aalst, Aalst, Belgium
🇧🇪Middelheim Ziekenhuis, Antwerpen, Belgium
🇧🇪ZOL Genk, Genk, Belgium
News
No news found